Not sure if there is recording.
I would probably check Beckman & Coulter website and youtube.
Every share holders should watch the webinar if available so that share holders know more about leronlimab for themselves.
This is a preview of the paper that will be published. If don't like reading and do not have science background, watching this will help alot.
Dr. Patterson mentioned that he is answering the questions that reviewer is asking. He says he won't mention the journal, which to me is something big, setting up for a big suspense and surprise!
His data were very convincing!
If clinical trial data are positive and his paper is published, then leronlimab will be the drug of choice, until something better comes out but do not see anything good in near future.
I am glad that Dr. Patterson did not hyped leronlimab (even though he could have) but just gave the facts, data, and what it can be capable of doing. He is not the most eloquent speaker but he presents like a scientist, which is what I would like hear if I am listening about science, not a scientist that has eloquent voice and dramatic presentation but without much data!
I bought 8K shared today because I am more convinced now than before after listening to Dr. Patterson!
News 
Market Data 
Discover 
AI
